Back

A conserved grain-associated immunosuppressive niche in Sudanese patients with mycetoma.

Osman, M.; Ashwin, H.; Calder, G.; O'Toole, P.; Bakhiet, S. M.; Musa, A. M.; Kaye, P. M.; Fahal, A. H.

2026-04-13 infectious diseases
10.64898/2026.04.09.26350374 medRxiv
Show abstract

Mycetoma is a neglected tropical disease caused by various bacterial and fungal pathogens that has a significant health impact across a broad geographically defined "mycetoma belt" spanning South America, Africa and Asia. Histologically, mycetoma is characterised by invasive and destructive granuloma development in the skin, deep tissues and bone, leading to tissue destruction, deformities and high morbidity. The presence of macroscopic, highly compacted pathogen microcolonies, or "grains," is a key diagnostic feature, and the formation of grains supports pathogen persistence and disease chronicity. However, there is a paucity of information on immune responses in mycetoma patients and on the relative importance of phylogeny and/or grains in establishing the local immune landscape. Here, we used spatial proteomics to examine the distribution of 43 immune-related proteins in surgical biopsies from 11 patients with mycetoma of bacterial (Actinomycetoma; Actinomadura pelletierii and Streptomyces somaliensis; n=6) and fungal (Eumycetoma; Madurella mycetomatis; n=5) origin. Using mixed-effects modelling, an exploratory analysis across species and pathogen classes revealed few significant differences in immune marker expression. In contrast, and independently of pathogen class, the cellular infiltrate closest to grain boundaries had higher per-cell expression of CD66b+, ARG1, and VISTA. The preferential accumulation of CD66b+ARG1+VISTA+ cells at grain boundaries was confirmed by quantitative immunofluorescence analysis. Hence, the local tissue microenvironment surrounding the mycetoma grain represents a specialised immunosuppressive niche, with parallels to the tumour microenvironment.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3102 papers in training set
Top 4%
12.4%
2
Frontiers in Immunology
586 papers in training set
Top 1.0%
6.8%
3
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 0.6%
4.9%
4
Nature Communications
4913 papers in training set
Top 36%
4.2%
5
Frontiers in Microbiology
375 papers in training set
Top 2%
4.0%
6
PLOS Pathogens
721 papers in training set
Top 3%
4.0%
7
European Journal of Immunology
57 papers in training set
Top 0.1%
3.7%
8
Journal of Fungi
31 papers in training set
Top 0.2%
3.6%
9
EMBO Molecular Medicine
85 papers in training set
Top 0.8%
2.7%
10
PLOS Neglected Tropical Diseases
378 papers in training set
Top 2%
2.7%
11
Journal of Infection
71 papers in training set
Top 0.7%
2.7%
50% of probability mass above
12
mBio
750 papers in training set
Top 6%
2.6%
13
eLife
5422 papers in training set
Top 32%
2.6%
14
eBioMedicine
130 papers in training set
Top 0.8%
2.1%
15
Pathogens
53 papers in training set
Top 0.3%
2.1%
16
Immunology
29 papers in training set
Top 0.5%
1.7%
17
Open Biology
95 papers in training set
Top 0.7%
1.7%
18
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.2%
19
JCI Insight
241 papers in training set
Top 5%
1.2%
20
iScience
1063 papers in training set
Top 21%
1.2%
21
PLOS ONE
4510 papers in training set
Top 60%
1.2%
22
The Lancet Microbe
43 papers in training set
Top 0.9%
1.0%
23
Open Forum Infectious Diseases
134 papers in training set
Top 2%
0.9%
24
mSphere
281 papers in training set
Top 5%
0.9%
25
Blood Advances
54 papers in training set
Top 1%
0.9%
26
Communications Biology
886 papers in training set
Top 21%
0.8%
27
Cell Reports Medicine
140 papers in training set
Top 7%
0.8%
28
PLOS Biology
408 papers in training set
Top 19%
0.8%
29
Science Immunology
81 papers in training set
Top 2%
0.8%
30
EBioMedicine
39 papers in training set
Top 1%
0.8%